Anti-cancer agents for breast cancer treatment during pregnancy
β Scribed by Paul Berveiller; Nicolas Veyrie; Roman Rouzier; Bruno Carbonne; Olivier Mir
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 32 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment with Centchroman (3,4-trans-2,2-dimethyl-3phenyl-4-p-(fl-pyrrolidinoethoxy) phenyl-7-methoxy chroman) has been evaluated in 4 male and 75 female patients with advanced breast cancer. The overall response rate, including both male and female cases, was 40.5%. Among the female patients, the
Adequate local-regional treatment of patients with primary operable breast cancer involves controlling multicentric disease in the breast, and axillary dissection to stage the disease and control it in the axilla, when present. Two options, showing equal survival rates in prospective, randomized stu